THE Therapeutic Goods Administration (TGA) has issued an alert to health professionals around the potential for overdose with oral methorexate (MTX), medicines associated with neuropsychiatric adverse events and clozapine GI effects - see details at tga.gov.au.
The above article was sent to subscribers in Pharmacy Daily's issue from 03 Jul 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 03 Jul 18
